Jorge Campos is a highly accomplished individual with a diverse background in healthcare strategy and mental health care. He is currently the Co-founder and Chief Business Officer (CBO) at Apoth, a revolutionary healthtech startup that is dedicated to utilizing data to transform the field of mental health care.

Apoth is at the forefront of next-generation interventions in high-risk behaviors such as suicide and drug abuse, leveraging advanced behavioral and biometric data collection. Jorge collaborates closely with renowned research institutions and hospitals to bring cutting-edge solutions to the table.

Jorge's educational journey led him to Harvard University, where he pursued a Bachelor's degree in Economics and Psychology, earning honors for his exceptional performance. Throughout his academic tenure, he received several prestigious accolades, including being recognized as a Coke Scholar, Dell Scholar, JKCF Scholar, Fortis Fellow, and Pfizer Breakthrough Fellow.

Prior to his role at Apoth, Jorge gained invaluable experience working in healthcare strategy and corporate development. He was a part of Lazard Healthcare M&A, where he contributed his expertise in navigating the intricacies of the healthcare industry. Additionally, he made significant contributions in Pfizer Corporate Development and Amgen Global Health Economics, further honing his skills and knowledge in the field.

Jorge's unique combination of expertise in healthcare strategy and his passion for leveraging data to drive innovation in mental health care make him an influential figure in the industry. With his remarkable achievements and unwavering dedication, Jorge is poised to continue making significant contributions towards revolutionizing mental health care.